D. Michelin

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.

D. Alberts, A. M. López, G. Anderson, 2010, Gynecologic oncology.

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Richard G. Moore, E. Kohn, D. Cella, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200).

D. Alberts, S. Wilczynski, M. Markman, 2007, Gynecologic oncology.

Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice.

A. Kaufmann, L. Gissmann, R. Potkul, 1997, Gynecologic oncology.

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.

A. Godwin, R. Mannel, K. Darcy, 2011, Gynecologic oncology.

Cherney versus midline vertical incision for myomectomy or hysterectomy of a significantly enlarged uterus.

D. Michelin, A. Kajdacsy‐Balla, J. D. De Lia, 1995, American journal of obstetrics and gynecology.